A review of the literature on treating multiple sclerosis (MS) aims to provide physicians with evidence-based information on the latest treatments for this chronic disease. The article, published in CMAJ (Canadian Medical ...
Apr 22, 2014
0
0
Just a few short weeks ago, dimethyl fumarate was approved in Europe as a basic therapy for multiple sclerosis. Although its efficacy has been established in clinical studies, its underlying mode of action was still unknown, ...
Apr 1, 2014
0
0
(Medical Xpress)—In patients with multiple sclerosis, the body turns on itself, launching an immune system attack that destroys the coating around nerve fibers in the central nervous system, leaving them exposed like bare ...
Mar 28, 2014
0
0
(HealthDay)—There has been an unusually high number of cases of thrombotic microangiopathy associated with severe or malignant hypertension in patients with multiple sclerosis who were receiving therapy with recombinant ...
Mar 27, 2014
0
0
Statins may provide doctors with an unlikely new weapon with which to slow the progression of multiple sclerosis (MS).
Mar 18, 2014
1
1
The human relationship with microbial life is complicated. At almost any supermarket, you can pick up both antibacterial soap and probiotic yogurt during the same shopping trip. Although there are types of bacteria that can ...
Mar 12, 2014
0
2
(Medical Xpress)—How does an autistic child take in information when he sits in a classroom abuzz with social activity? How long does it take someone with multiple sclerosis, which slows activity in the brain, to process ...
Mar 6, 2014
0
0
The role of the so-called "obesity hormone" leptin and hormones used for birth control in the development of multiple sclerosis (MS) is examined in two new studies released today that will be presented at the American Academy ...
Feb 27, 2014
0
0
Kessler Foundation researchers have found that among persons with multiple sclerosis, self-generation may be influenced by variables such as task meaningfulness during learning and memory. They also found that type of task ...
Feb 21, 2014
0
0
A new study describes the complexity of the new T cell repertoire following immune-depleting therapy to treat multiple sclerosis, improving our understanding of immune tolerance and clinical outcomes.
Feb 17, 2014
0
0
